Fortress Biotech, Inc.
Ticker: 1429260
P/L Snapshot
Q3 FY26 · consolidated
vs Q2 FY26·vs Q3 FY25
Revenue
19.16
+2.4%+8.7%
Expenditure
26.35
-8.3%+7.8%
Net Profit
-5.85
-1144.7%-200.0%
OPM %
-37.54%
+15.91pp+1.09pp
Shareholding
Pattern breakdown
P/L Trends
(in millions)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingFBIO
202617Jun
Board Meeting
Annual Meeting of Stockholders to vote on the election of se…
SEC Filing ↗